BlossomHill Therapeutics, Inc. Common Stock

BLSMNASDAQ • USD
14.97 USD
↗ 1.32 (9.63%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

BlossomHill Therapeutics, Inc. Common Stock (BLSM) is currently trading at $14.97. Technical indicators currently signal "Sell". Notable factors include a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$13.69
High?$15.06
Low?$13.15
Prev. Close?$13.65
Volume?237.2K
Avg. Volume?N/A
VWAP?$14.10
Bid / Ask
Bid?$14.60 × 100
Ask?$14.99 × 500
Spread?$0.39
Midpoint?$14.80
Valuation & Ratios
Market Cap?433.9M
Shares Out?N/A
Float?20.2M
Float %?65.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.
Employees
71
Market Cap
433.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-08-07
Address
10255 SCIENCE CENTER DRIVE
SAN DIEGO, CA
Phone: 858-732-3880
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.92%Low
Short Interest?590.1K
Days to Cover?4.7
Free Float20.2M
Avg Daily Volume126.9K
Settlement Date2026-10-30